BR112012001592A2 - preparação de (r) e (s) -n- (3,4-difluoro-2-(2-fluoro-4-iodofe-nilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopro-pano-1-sulfonamida e derivados protegidos dos mesmos. - Google Patents

preparação de (r) e (s) -n- (3,4-difluoro-2-(2-fluoro-4-iodofe-nilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopro-pano-1-sulfonamida e derivados protegidos dos mesmos.

Info

Publication number
BR112012001592A2
BR112012001592A2 BR112012001592A BR112012001592A BR112012001592A2 BR 112012001592 A2 BR112012001592 A2 BR 112012001592A2 BR 112012001592 A BR112012001592 A BR 112012001592A BR 112012001592 A BR112012001592 A BR 112012001592A BR 112012001592 A2 BR112012001592 A2 BR 112012001592A2
Authority
BR
Brazil
Prior art keywords
iodophenylamino
dihydroxypropyl
cyclopropane
sulfonamide
difluoro
Prior art date
Application number
BR112012001592A
Other languages
English (en)
Inventor
Andreas Maderna
Jean-Michel Vernier
Original Assignee
Ardea Bioscences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012001592(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardea Bioscences Inc filed Critical Ardea Bioscences Inc
Publication of BR112012001592A2 publication Critical patent/BR112012001592A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/16Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR112012001592A 2009-07-24 2010-07-10 preparação de (r) e (s) -n- (3,4-difluoro-2-(2-fluoro-4-iodofe-nilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopro-pano-1-sulfonamida e derivados protegidos dos mesmos. BR112012001592A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22850109P 2009-07-24 2009-07-24
US22850909P 2009-07-24 2009-07-24
PCT/EP2010/004222 WO2011009541A1 (en) 2009-07-24 2010-07-10 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Publications (1)

Publication Number Publication Date
BR112012001592A2 true BR112012001592A2 (pt) 2016-03-08

Family

ID=42830488

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012001592A BR112012001592A2 (pt) 2009-07-24 2010-07-10 preparação de (r) e (s) -n- (3,4-difluoro-2-(2-fluoro-4-iodofe-nilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopro-pano-1-sulfonamida e derivados protegidos dos mesmos.

Country Status (32)

Country Link
US (3) US8513443B2 (pt)
EP (1) EP2462111B1 (pt)
JP (1) JP5776115B2 (pt)
KR (1) KR101763437B1 (pt)
CN (2) CN102471246B (pt)
AR (1) AR079183A1 (pt)
AU (1) AU2010275780B2 (pt)
BR (1) BR112012001592A2 (pt)
CA (2) CA2768788C (pt)
CL (1) CL2012000192A1 (pt)
CO (1) CO6491075A2 (pt)
CR (1) CR20120044A (pt)
CU (1) CU24113B1 (pt)
DO (1) DOP2012000017A (pt)
EA (1) EA023623B1 (pt)
EC (1) ECSP12011621A (pt)
GT (1) GT201200017A (pt)
HK (2) HK1171218A1 (pt)
HN (1) HN2012000142A (pt)
IL (1) IL217312A (pt)
IN (1) IN2012DN00696A (pt)
MA (1) MA33452B1 (pt)
MX (2) MX2012001063A (pt)
MY (1) MY160421A (pt)
NZ (1) NZ597738A (pt)
PE (1) PE20120573A1 (pt)
PH (1) PH12014500158A1 (pt)
SG (1) SG177535A1 (pt)
TN (1) TN2012000027A1 (pt)
TW (1) TWI524890B (pt)
UY (1) UY32800A (pt)
WO (1) WO2011009541A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備
KR101939682B1 (ko) * 2011-05-27 2019-01-17 바이엘 인텔렉쳐 프로퍼티 게엠베하 N-{3,4-디플루오로-2-〔(2-플루오로-4-요오도페닐)아미노〕-6-메톡시페닐}-1-[2,3-디하이드록시프로필]사이클로프로판설폰아미드의 키랄 합성
EP2796455A4 (en) * 2011-12-19 2015-08-19 Sumitomo Chemical Co PROCESS FOR PRODUCING SULFONATE
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495118B (zh) * 2005-07-21 2012-09-05 阿迪亚生命科学公司 Mek的n-(芳基氨基)磺酰胺抑制剂
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
WO2009018238A1 (en) * 2007-07-30 2009-02-05 Ardea Biosciences, Inc. Combinations of mek inhibitors and raf kinase inhibitors and uses thereof
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
CA2649122C (en) 2006-04-18 2015-06-30 Ardea Biosciences, Inc. Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
SG189784A1 (en) * 2008-04-14 2013-05-31 Ardea Biosciences Inc Compositions and methods for preparing and using same
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備

Also Published As

Publication number Publication date
HK1198364A1 (zh) 2015-04-10
US20130261320A1 (en) 2013-10-03
EP2462111A1 (en) 2012-06-13
IL217312A (en) 2017-02-28
CN102471246A (zh) 2012-05-23
IN2012DN00696A (pt) 2015-06-19
NZ597738A (en) 2014-03-28
DOP2012000017A (es) 2012-05-15
PE20120573A1 (es) 2012-05-17
CA2768788C (en) 2018-01-09
CO6491075A2 (es) 2012-07-31
AU2010275780A1 (en) 2012-02-02
US9296686B2 (en) 2016-03-29
MX2012001063A (es) 2012-03-26
AU2010275780B2 (en) 2015-10-22
CU24113B1 (es) 2015-08-27
US8884058B2 (en) 2014-11-11
WO2011009541A1 (en) 2011-01-27
CU20120014A7 (es) 2012-06-21
CA2768788A1 (en) 2011-01-27
EA201200175A1 (ru) 2012-12-28
JP5776115B2 (ja) 2015-09-09
PH12014500158B1 (en) 2015-09-07
MY160421A (en) 2017-03-15
ECSP12011621A (es) 2012-02-29
GT201200017A (es) 2013-12-19
HK1171218A1 (en) 2013-03-22
TWI524890B (zh) 2016-03-11
IL217312A0 (en) 2012-02-29
PH12014500158A1 (en) 2015-09-07
EA023623B1 (ru) 2016-06-30
KR101763437B1 (ko) 2017-07-31
CA2990097A1 (en) 2011-01-27
TW201113017A (en) 2011-04-16
UY32800A (es) 2011-01-31
US20150274651A1 (en) 2015-10-01
CL2012000192A1 (es) 2012-10-05
CN103848808B (zh) 2016-02-10
AR079183A1 (es) 2012-01-04
SG177535A1 (en) 2012-03-29
US8513443B2 (en) 2013-08-20
CN103848808A (zh) 2014-06-11
EP2462111B1 (en) 2016-03-30
CR20120044A (es) 2012-03-12
JP2013500242A (ja) 2013-01-07
KR20120032536A (ko) 2012-04-05
MX344965B (es) 2017-01-12
TN2012000027A1 (en) 2013-09-19
HN2012000142A (es) 2015-06-08
CN102471246B (zh) 2015-08-26
US20120178946A1 (en) 2012-07-12
MA33452B1 (fr) 2012-07-03

Similar Documents

Publication Publication Date Title
NO2017002I2 (no) Kobicistat eller farmasøytisk akseptabelt salt derav og atazanavir eller farmasøytisk akseptabelt salt derav
IL238607A (en) Derivatives n - [(cyclic group) sulfonyl] benzamide and their use
BRPI0912480A2 (pt) compostos de monoalquiltina de alta pureza e usos dos mesmos
BR112013015592A8 (pt) derivados de biciclo-[3.2.1]-octilamida e usos dos mesmos
IL220545B (en) Derivatives of -n cycloalkylalkyl- n, (2-carboxy-5-alkynyl-thiane--3 yl), cycloalkane-amide and their uses for the treatment of flaviviridae virus infection
BRPI0807495A2 (pt) Adjuvantes e métodos de emrpego dos mesmos
BRPI0715342A2 (pt) Derivados de 6-carboxi-normorfinano, síntese e usos dos mesmos
BRPI0812909A2 (pt) Derivados de guanina policíclica e métodos de uso dos mesmos.
BRPI0713736A2 (pt) Derivados de tetralina e indano e emprego destes
HRP20130585T1 (en) Alkylthiazol carbamate derivatives, preparation thereof and their use as faah inhibitors
BRPI0914900A2 (pt) compostos de amida, métodos de preparação e usos dos mesmos
BR112012019860A2 (pt) Utilização de saponinas, principio ativo moluscicida composto destinado ao combate aos moluscos noci vos terrestre ou aquatico processo de combate aos moluscos nocivos e proscesso de combate aos moluscos nocivos aquaticos
BRPI1011822A2 (pt) "compostos de 3-substituída-8-substituída-3h-imidazo[5,1-d][1,2,3,5-tetrazin-4-ona e sua aplicação"
BRPI1014904A2 (pt) derivados de quinazolinadiona, preparação dos mesmos e vários usos terapêuticos dos mesmos.
BR112012001592A2 (pt) preparação de (r) e (s) -n- (3,4-difluoro-2-(2-fluoro-4-iodofe-nilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopro-pano-1-sulfonamida e derivados protegidos dos mesmos.
BR112013010709A2 (pt) derivado de ácido trans-2-decenoico e agente farmacêutico contendo o mesmo
DK1896399T3 (da) Biphenyl- og naphthylphenyl-hydroxamsyre-derivater
BRPI0916739A2 (pt) síntese e formulações de sais de mostarda de isofosforamida e análogos dos mesmos
BRPI0822143A2 (pt) derivados de dicicloaza-alcano, processos de preparação e usos médicos dos mesmos
FR2912654B1 (fr) Association medicamenteuse comprenant du phloroglucinol et du paracetamol
BR112013010990A2 (pt) processo para a preparação de n-(benzil) ciclopanaminas, uso e derivados
DK2001445T3 (da) Farmaceutiske sfæroider
BR112012000656A2 (pt) novos derivados de tiofenocarboxamida e uso farmacêutico dos mesmos.
UA106762C2 (uk) Спосіб одержання (r)- та (s)-n-(3,4-дифтор-2-(2-фтор-4-йодфеніламіно)-6-метоксифеніл)-1-(2,3-дигідроксипропіл)циклопропан-1-сульфанаміду та його захищених похідних
BRPI0923853A2 (pt) análogos de gpl-1 e usos dos mesmos.

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: ARDEA BIOSCIENCES, INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements